Pharmarise 1Q net loss widens to Y36.0M from Y18.0M
For the 1Q ended August 31, Pharmarise reported revenue of Y17.24 bln (vs Y16.75 bln), operating profit of Y68.0 mln (vs Y152.0 mln), pretax profit of Y79.0 mln (vs Y115.0 mln), and net profit/loss of Y36.0 mln (vs Y18.0 mln).